Pendal Group LTD Gilead Sciences, Inc. Call Options Transaction History
Pendal Group LTD
- $12.2 Billion
- Q4 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GILD
# of Institutions
2,099Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$14.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$13.6 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$8.42 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$7.09 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.8 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $147B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...